# Evaluation of CureXcell® in Treating Lower Extremity Chronic Ulcers in Adults With Diabetes

> **NCT01421966** · PHASE3 · COMPLETED · sponsor: **Macrocure Ltd.** · enrollment: 285 (actual)

## Conditions studied

- Lower Extremity Chronic Ulcers in Diabetics

## Interventions

- **BIOLOGICAL:** CureXcell®
- **BIOLOGICAL:** Sham injection

## Key facts

- **NCT ID:** NCT01421966
- **Lead sponsor:** Macrocure Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2015-02
- **Final completion:** 2015-10
- **Target enrollment:** 285 (ACTUAL)
- **Last updated:** 2015-12-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01421966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01421966, "Evaluation of CureXcell® in Treating Lower Extremity Chronic Ulcers in Adults With Diabetes". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01421966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*